What the announcement does highlight is that PAA had not...

What the announcement does highlight is that PAA had not initiated discovery of the Trial Clinics last year when the trial was proposed to begin in October.

The Trial Sites have not been identified and booked to coincide with Initial Tablet Production schedule or even the second timeframe given .

The second page of the ASX Announcement.
Key Material Terms
• Feasibility study to identify up to six sites willing to conduct the trial
• Initial time frame for identification of the six sites is 2 months
• The fee payable under the agreement is not material to the company

what seems to have occurred is the Company probably had every intention of Tablet Production but their actions dont confirm this by way of not having Trial Sites IDENTIFIED, BOOKED and awaiting the initial scheduled tablets..

It would seem the Company want to receive the second Tranche of the MND Money " Recruitment of MND Patients" before moving forward on the Covid front.

Now I don't want to sound callous but you could recruit MND patients all day long unlike Covid patients who you literally recruit at the door due to having an identified infection period,,, regrettably MND sufferers will not be remedied of MND ,,

Tick Tock money is burning $$$ and PAA are being exceptionally Prudent but time and money and all..........

Obviously not enough in the tank to make it to the Oppies in October 2023??? so what "K9" Deal? That really needs a Phase III or Phase III Partner yet "anyone heard from Kim"

Best of luck to all holders ... hoping that the messaging increases surrounding the Covid Trial , thats where the market focus is and plenty of new investors